- Home
- TPB vs BCAX Comparison
TPB vs BCAX Comparison
Compare TPB & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPB
- BCAX
- Stock Information
- Founded
- TPB 1988
- BCAX 2018
- Country
- TPB United States
- BCAX United States
- Employees
- TPB N/A
- BCAX N/A
- Industry
- TPB Tobacco
- BCAX
- Sector
- TPB Consumer Discretionary
- BCAX
- Exchange
- TPB Nasdaq
- BCAX NYSE
- Market Cap
- TPB 1.1B
- BCAX 1.0B
- IPO Year
- TPB 2016
- BCAX 2024
- Fundamental
- Price
- TPB $58.16
- BCAX $12.08
- Analyst Decision
- TPB Strong Buy
- BCAX Strong Buy
- Analyst Count
- TPB 4
- BCAX 5
- Target Price
- TPB $68.75
- BCAX $41.33
- AVG Volume (30 Days)
- TPB 191.6K
- BCAX 591.3K
- Earning Date
- TPB 02-26-2025
- BCAX 02-16-2025
- Dividend Yield
- TPB 0.48%
- BCAX N/A
- EPS Growth
- TPB 283.79
- BCAX N/A
- EPS
- TPB 2.48
- BCAX N/A
- Revenue
- TPB $409,407,000.00
- BCAX N/A
- Revenue This Year
- TPB $3.01
- BCAX N/A
- Revenue Next Year
- TPB $2.26
- BCAX N/A
- P/E Ratio
- TPB $23.46
- BCAX N/A
- Revenue Growth
- TPB 0.28
- BCAX N/A
- 52 Week Low
- TPB $21.98
- BCAX $11.56
- 52 Week High
- TPB $66.18
- BCAX $28.09
- Technical
- Relative Strength Index (RSI)
- TPB 50.82
- BCAX N/A
- Support Level
- TPB $56.12
- BCAX N/A
- Resistance Level
- TPB $58.26
- BCAX N/A
- Average True Range (ATR)
- TPB 1.70
- BCAX 0.00
- MACD
- TPB -0.13
- BCAX 0.00
- Stochastic Oscillator
- TPB 54.30
- BCAX 0.00
About TPB Turning Point Brands Inc.
Turning Point Brands Inc operates as manufacturer, marketer, provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in three segments namely Zig-Zag products; Stoker's products and NewGen products. The company generates maximum revenue from the Zig-Zag products segment.
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.